GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (AMEX:CYBN) » Definitions » EV-to-FCF
中文

Cybin (CYBN) EV-to-FCF

: -5.50 (As of Today)
View and export this data going back to 2020. Start your Free Trial

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cybin's Enterprise Value is $244.02 Mil. Cybin's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-44.38 Mil. Therefore, Cybin's EV-to-FCF for today is -5.50.

The historical rank and industry rank for Cybin's EV-to-FCF or its related term are showing as below:

CYBN' s EV-to-FCF Range Over the Past 10 Years
Min: -28.41   Med: -2.76   Max: 0.88
Current: -5.97

During the past 4 years, the highest EV-to-FCF of Cybin was 0.88. The lowest was -28.41. And the median was -2.76.

CYBN's EV-to-FCF is ranked worse than
100% of 389 companies
in the Biotechnology industry
Industry Median: 4.27 vs CYBN: -5.97

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-23), Cybin's stock price is $0.3566. Cybin's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.208. Therefore, Cybin's PE Ratio for today is At Loss.


Cybin EV-to-FCF Historical Data

The historical data trend for Cybin's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23
EV-to-FCF
- -7.71 -2.52 -1.72

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.13 -1.72 -1.90 -3.72 -2.96

Competitive Comparison

For the Biotechnology subindustry, Cybin's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cybin EV-to-FCF Distribution

For the Biotechnology industry and Healthcare sector, Cybin's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Cybin's EV-to-FCF falls into.



Cybin EV-to-FCF Calculation

Cybin's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=244.018/-44.381
=-5.50

Cybin's current Enterprise Value is $244.02 Mil.
Cybin's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-44.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cybin  (AMEX:CYBN) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cybin's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.3566/-0.208
=At Loss

Cybin's share price for today is $0.3566.
Cybin's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.208.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Cybin EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Cybin's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cybin (CYBN) Business Description

Traded in Other Exchanges
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.